期刊文献+

西罗莫司纳米脂质载体固化制剂的制备 被引量:4

Preparation of Solidification Preparation of Sirolimus Nanostructured Lipid Carriers
原文传递
导出
摘要 采用冷冻干燥法以微晶纤维素Avicel PH-101与聚乙烯吡咯烷酮(PVP)K30的混合物(4:1,w,%)为吸附性粉末固化西罗莫司纳米脂质载体分散液,并以再分散时间、平均粒径及分布、流动性和泄漏率等为指标,采用单因素试验优化固化处方。结果表明,3批按优化方法制备的西罗莫司纳米脂质载体固化制剂的休止角为(42.65±0.80)。,振实密度为(0.79±0.03)g/m1,且含量均匀度良好,再分散时间为(10.0±0.4)min,再分散液粒径(132.7+2.6)nm,分布系数0.297±0.01,ξ电位(-12.8±1.05)mV,冻干前后的泄漏率为(10.80±0.41)%。 ABSTRACT: The sirolimus nanostructured lipid carriers was solidified by freeze-drying method with the mixture of microcrystalline cellulose (Avicel PH-101) and polyvinyl pyrrolidone (PVP) K30 (4 : 1, w/w) as the adsorption powder. The preparation was optimized by single factor test with dispersing time, average particle size and distribution, fluidity and leakage rate as the indexes. The results showed that the angle of repose and tap density of three batches of the optimized solidified powder were (42.65±0.80) ° and (0.79±0.03) g/ml with good content uniformity. The solidified powder could disperse within (10.0±0.4)min and the average particle size and polydispersity index (PDI) of its redispersing solution were (132.7±2.6)nm and 0.297±0.01 with the ζ potential of (-12.8±1.05)mV. The leakage rate of the products was (10.80±0.41) %.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2012年第7期562-567,共6页 Chinese Journal of Pharmaceuticals
基金 福建省自然科学基金(2010J01218)
关键词 纳米脂质载体固化制剂 西罗莫司 固化 吸附性粉末 冷冻干燥法 solidification preparation of nanostructured lipid carriers sirolimus solidification adsorption powder freeze-drying method
  • 相关文献

参考文献6

  • 1Zhuang CY, Li N, Wang M, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability [J]. Int J Pharm, 2010, 394(1-2): 179-185. 被引量:1
  • 2Zhang Z, Bu H, Gao Z, et al. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats [J]. Int J Pharm, 2010, 394 (1-2) : 147-153. 被引量:1
  • 3Trevaskis NL, Charman WN, Porter CJ. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update [J]. Adv Drug Deli Rev, 2008, 60 (6) : 702-716. 被引量:1
  • 4周华锋,马全红,丁艺,夏强,旷英姿,郝晓帧,顾宁.咪喹莫特纳米结构脂质载体的可控制备及表征[J].过程工程学报,2006,6(4):598-602. 被引量:5
  • 5Mfiller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs [J]. Int J Pharm, 2002, 242 (1-2) : 121-128. 被引量:1
  • 6赵鹤皋.冷冻干燥与设备[M].武汉:华中科技大学出版社,2004:16. 被引量:1

二级参考文献10

  • 1陆杨燕,夏强,夏勇,马全红,顾宁.载药微乳液相行为的研究[J].物理化学学报,2005,21(1):98-101. 被引量:19
  • 2Radtke M,Souto E B,Muller R H.Nanostructured Lipid Carriers:A Novel Generation of Solid Lipid Drug Carriers[J].Pharm.Technol.Europe,2005,17(4):45-50. 被引量:1
  • 3Jenning V,Thunemann A F,Gohla S H.Characterisation of a Novel Solid Lipid Nanoparticle Carrier System Based on Binary Mixtures of Liquid and Solid Lipids[J].Int.J.Pharm.,2000,199(2):167-177. 被引量:1
  • 4Muller R H,Radtke M,Wissing S A.Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) in Cosmetic and Dermatological Preparations[J].Adv.Drug Deliv.Rev.,2002,54(1):131-155. 被引量:1
  • 5Souto E B,Wissing S A,Barbosa C M,et al.Development of a Controlled Release Formulation Based on SLN and NLC for Topical Clotrimazole Delivery[J].Int.J.Pharm.,2004,278(1):71-77. 被引量:1
  • 6Gupta A K,Browne M,Bluhm R.Imiquimod:A Review[J].J.Cutan.Med.Surg.,2002,6(6):554-562. 被引量:1
  • 7Wolfgang M,Karsten M.Solid Lipid Nanoparticles Production,Characterization and Applications[J].Adv.Drug Deliv.Rev.,2001,47(2):165-196. 被引量:1
  • 8Lim S J,Kim C K.Formulation Parameters Determining the Physicochemical Characteristics of Solid Lipid Nanoparticles Loaded with All-trans Retinoic Acid[J].Int.J.Pharm.,2002,243(2):135-146. 被引量:1
  • 9Vobalaboina V,Kopparam M.Preparation,Characterization and in vitro Release Kinetics of Clozapine Solid Lipid Nanoparticles[J].J.Controlled Release,2004,95(3):627-638. 被引量:1
  • 10Annette M,Cora S,Wolfgang M.Solid Lipid Nanoparticles (SLN) for Controlled Drug Delivery-Drug Release and Release Mechanism[J].Europ.J.Pharm.Biopharm.,1998,45(2):149-155. 被引量:1

共引文献4

同被引文献50

  • 1沈丽琳.羟丙甲纤维素在药物制剂方面的应用与研究[J].中国药业,2007,16(12):64-64. 被引量:16
  • 2Brattstrom C,Wilczek H, Tyden G. Hypertriglyceridemia in re- nal transplant recipients treated with sirolimus[J]. Transplant Proc, 1998,30: 3950-3951. 被引量:1
  • 3Hu X, Lin C, Chen D, et al. Sirolimus solid self-microemulsify- ing pellets: Formulation development, characterization and bio- availability evaluation[J]. Int J Pharmt, 2012,438 ( 1-2 ) : 123- 133. 被引量:1
  • 4Spilman P, Podlutskaya N, Hart MJ,et al. Inhibition of mTOR by rapamycin abblishes cognitive deficits and reduces amyloid-beta levels in amouse model of Alzheimer' s disease [ J ]. PLoS One, 2010, 5 (4) : e9979. 被引量:1
  • 5Emami S, Valizadeh H, Islambulchilar Z, et al. Development and Physicochemical Characterization of Sirolimus Solid Dispersions Prepared by Solvent Evaporation Method[ J], Adv Pharm Bull, 2014, 4 (4) : 369-374. 被引量:1
  • 6Park SM, Kim MS, Park SJ, et al. Novel temperature-triggered liposome with high stability: Formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU) [ J ]. J Control Release, 2013,170(3) :373-379. 被引量:1
  • 7Fu J, Wang D, Wang T, et al. High Entrapment Efficiency of Chitosan/Polylactic Acid/Tripolyphotspate Nanosized Microcapsules for Rapamycin by an Emulsion-Evaporation Approach [ J ]. J Biomed Nanotechnol, 2010, 6(6): 725-728. 被引量:1
  • 8Zhuang CY, Li N, Wang M, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability[ J]. Int J Pharm, 2010, 394( 1-2 ) : 179185. 被引量:1
  • 9Zhang Z, Bu H, Gao Z, et al. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats[J]. Int J Pharm, 2010, 394(1-2): 147-153. 被引量:1
  • 10Kim MS, Kim JS, Park H J, et al. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process [ J ]. Int J Nanomedicine, 2011 ( 6 ) : 29973009. 被引量:1

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部